Skip to main content
Figure 4 | BMC Nephrology

Figure 4

From: A multicenter, randomized, double-blind study comparing different FK778 doses (manitimus) with tacrolimus and steroids vs. MMF with tacrolimus and steroids in renal transplantation

Figure 4

Estimated Rate of Patients Free from Local Biopsy-proven Acute Rejection (Kaplan-Meier Method). Differences in the estimated rate of patients free from biopsy proven acute rejection at week 24 between the high level FK778 (62.3%) vs. MMF (82%) groups were significant (P = 0.014, Chi-square test). Differences between the two treatment groups were also significant at month 12 when estimated rates were 62.3% in the high level FK778 vs. 79.4% in the MMF group (P = 0.023, Chi-square test).

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us